Company: RPID
Filing Date: 2025-05-09
Form Type: 10-Q
Source: 0001380106-25-000102
Chunk: 280

Company: RAPID MICRO BIOSYSTEMS, INC.
Filing Date: 2025-05-09
Form: 10-Q
Item: Part I, Item 1
Chunk 280
---
 into employment with the Company within the meaning of Rule 5635(c)(4) of the Nasdaq Listing Rules. The Inducement Plan provides for the grant of equity-based awards in the form of nonstatutory stock options, stock appreciation rights, restricted stock awards, restricted stock unit awards, and dividend equivalent rights. The Inducement Plan was adopted by the Company's board of directors without stockholder approval pursuant to Rule 5635(c)(4) of the Nasdaq Listing Rules. In February 2024, the Company amended the Inducement Plan to reserve an additional 225,000 shares of its Class A common stock. The amendment was adopted by the compensation committee of the Company's board of directors, without stockholder approval pursuant to Rule 5635(c)(4) of the Nasdaq Listing Rules. As of December 31, 2024, 217,013 shares were available for future issuance under the Inducement Plan. In February 2025, the Company amended the Inducement Plan to reserve an additional 476,000 shares of its Class A common stock. The 

19

Table of Contents

amendment was adopted by the Company's board of directors, without stockholder approval pursuant to Rule 5635(c)(4) of the Nasdaq Listing Rules. As of March 31, 2025, 217,013 shares were available for future issuance under the Inducement Plan. Stock optionsThe following table presents, on a weighted average basis, the assumptions used in the Black-Scholes option-pricing model to determine the grant-date fair value of stock options granted to employees and directors:Three Months Ended March 31,20252024Risk-free interest rate 4.3 %4.1 %Expected term (in years)6.16.0Expected volatility51.0 %49.5 %Expected dividend yield0 %0 %Stock optionsThe following table summarizes the Company’s stock option activity since December 31, 2024:Number of sharesWeighted average exercise priceWeighted average remaining contractual termAggregate intrinsic value(in years)(in thousands)Outstanding as of December 31, 20246,296,505$2.39 6.18$135 Granted 1,011,0003.50 Exercised(273,385)1.07 $330 Expired(73,864)8.32 Forfeited(6,530)0.98 Outstanding as of